Serge Zaretsky
About Serge Zaretsky
Serge Zaretsky is the Associate Director of Oncology Competitive Intelligence at Bristol Myers Squibb in Princeton, New Jersey, with a background in process and medicinal chemistry, biochemistry, and pharmacology.
Title
Serge Zaretsky currently holds the position of Associate Director, Oncology Competitive Intelligence at Bristol Myers Squibb based in Princeton, New Jersey, United States.
Professional Experience at Bristol Myers Squibb
Serge Zaretsky has had a progressive career at Bristol Myers Squibb. He currently serves as the Associate Director, Oncology Competitive Intelligence. Previously, he was the Senior Manager, Oncology Competitive Intelligence for 9 months in 2020. Before that, he worked as a Senior Research Investigator I from 2018 to 2020 and as a Research Investigator II from 2015 to 2018, both positions based in the Greater New York City Area.
Early Career and Research Experience
Serge Zaretsky started his career with notable research roles. He was a Senior Research Scientist at Alphora Research Inc. in Toronto, Ontario, Canada from 2014 to 2015. His earlier academic roles include being a Researcher and Ph.D. Candidate in the Yudin Group at the University of Toronto from 2009 to 2014. Additionally, he worked as a Research Assistant in the Tsantrizos Group and Moitessier Group at McGill University in 2009, and conducted an independent research project at the Stone Pain Lab at McGill University in 2008.
Education and Academic Background
Serge Zaretsky holds a Doctor of Philosophy (Ph.D.) in Organic Chemistry from the University of Toronto, where he studied from 2009 to 2014. He also has a Bachelor of Science (B.Sc.) in Biochemistry from McGill University, completed from 2004 to 2009. His academic background is multi-disciplinary, encompassing process and medicinal chemistry, biochemistry, and pharmacology.
Industry Skills and Expertise
Serge Zaretsky is known for his strong organizational skills and leadership abilities in cross-functional teams. He has a keen interest in understanding the biopharma competitive landscape through synthesizing information from clinical literature and competitive intelligence sources. Over his career, he has developed expertise in process and medicinal chemistry, biochemistry, and pharmacology.